Evidence map›Paper›PMID 25033285›Full record

ArticlePloS one2014

Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) programme in Zomba, Malawi.

Beth Rachlis, Donald C Cole, Monique van Lettow, Michael Escobar, Adamson S Muula, Farah Ahmad, James Orbinski, Adrienne K Chan

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Beth RachlisDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Donald C ColeDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Monique van LettowDalla Lana School of Public Health, University of Toronto, Toronto, Canada; Dignitas International, Zomba, Malawi.
Michael EscobarDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Adamson S MuulaCollege of Medicine, University of Malawi, Blantyre, Malawi.
Farah AhmadSchool of Health Policy and Management, York University, Toronto, Canada.
James OrbinskiCentre for International Governance Innovation, Waterloo, Canada.
Adrienne K ChanDalla Lana School of Public Health, University of Toronto, Toronto, Canada; Dignitas International, Zomba, Malawi; Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Canada.

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundIdentifying follow-up (FU) visit patterns, and exploring which factors influence them are likely to be useful in determining which patients on antiretroviral therapy (ART) may become Lost to Follow-Up (LTFU). Using an operation and implementation research approach, we sought 1) to describe the timing of FU visits amongst patients who have been on ART for shorter and longer periods of time; and 2) to determine the median time to late visits, and 3) to identify specific factors that may be associated with these patterns in Zomba, Malawi. METHODS AND

findingsUsing routinely collected programme monitoring data from Zomba District, we performed descriptive analyses on all ART visits among patients who initiated ART between Jan. 1, 2007-June 30, 2010. Based on an expected FU date, each FU visit was classified as early (≥4 day before an expected FU date), on time (3 days before an expected FU date/up to 6 days after an expected FU date), or late (≥7 days after an expected FU date). In total, 7,815 patients with 76417 FU visits were included. Ninety-two percent of patients had ≥2 FU visits. At the majority of visits, patients were either on time or late. The median time to a first late visit among those with 2 or more visits was 216 days (IQR: 128-359). Various patient- and visit-level factors differed significantly across Early, On Time, and Late visit groups including ART adherence and frequency of, and type of side effects. DISCUSSION: The majority of patients do not demonstrate consistent FU visit patterns. Individuals were generally on ART for at least 6 months before experiencing their first late visit. Our findings have implications for the development of effective interventions that meet patient needs when they present early and can reduce patient losses to follow-up when they are late. In particular, time-varying visit characteristics need further research.

Indexed as

Antiretroviral Therapy, Highly ActivePatient CompliancePatient DropoutsAcquired Immunodeficiency SyndromeAdolescentAdultAgedAged, 80 and overAmbulatory CareAnti-HIV AgentsFemaleHealth Services Needs and DemandHumansMalawiMaleMiddle AgedAnti-HIV Agents

Identifiers

PMID25033285
PMCPMC4102478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.